Vanguard CIV Canine Influenza Vaccine H3N2 and H3N8
فانغارد سي آي في لقاح إنفلونزا الكلاب الثنائي المعطل
Vanguard CIV is an inactivated bivalent viral vaccine containing killed Canine Influenza Virus subtypes H3N2 and H3N8. Indicated for the active vaccination of healthy dogs 8 weeks of age or older as an aid in the control of disease and lung lesions associated with canine influenza infection.
Dosage Form
N/A
Product Type
Biological
Manufacturer
Package
Pack of 25 x 1 mL single-dose vials
Dosages
No dosage information available.
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
Indications
-
Vaccination of healthy dogs 8 weeks of age or older as an aid in the control of disease associated with Canine Influenza Virus subtypes H3N2 and H3N8.
تحصين الكلاب من عمر 8 أسابيع فما فوق للمساعدة في السيطرة على والوقاية من فيروس إنفلونزا الكلاب بالنمطين H3N2 و H3N8 والحد من حدة الأعراض الرئوية وإفراز الفيروس.
Contraindications
No contraindications information available.
Precautions
-
Contains thimerosal, gentamicin, and amphotericin B as preservatives. Epinephrine should be administered if anaphylaxis occurs.
يحتوي على مواد حافظة ومضادات حيوية؛ يجب توفير الأدرينالين للتعامل مع أي رد فعل تحسسي فوري.
Side Effects
-
Transient localized injection site swelling, mild lethargy, or low-grade fever resolving within 24 hours.
تورم موضعي خفيف في موضع الحقن أو خمول عابر يزول خلال 24 ساعة.
Images
Documents
-
Download
Vanguard CIV Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.